<code id='0B996690DA'></code><style id='0B996690DA'></style>
    • <acronym id='0B996690DA'></acronym>
      <center id='0B996690DA'><center id='0B996690DA'><tfoot id='0B996690DA'></tfoot></center><abbr id='0B996690DA'><dir id='0B996690DA'><tfoot id='0B996690DA'></tfoot><noframes id='0B996690DA'>

    • <optgroup id='0B996690DA'><strike id='0B996690DA'><sup id='0B996690DA'></sup></strike><code id='0B996690DA'></code></optgroup>
        1. <b id='0B996690DA'><label id='0B996690DA'><select id='0B996690DA'><dt id='0B996690DA'><span id='0B996690DA'></span></dt></select></label></b><u id='0B996690DA'></u>
          <i id='0B996690DA'><strike id='0B996690DA'><tt id='0B996690DA'><pre id='0B996690DA'></pre></tt></strike></i>

          entertainment

          entertainment

          author:fashion    Page View:4991
          STAT

          What if CRISPR isn’t all that commercial? How does the NurOwn story end? And how do you pronounce “Bayer”?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Live from Boston at the 2023 STAT Summit, we discuss the latest news in the life sciences, including a milestone in genome editing, a twist in the search for ALS treatments, and the polarizing process of saying words in biotech.

          advertisement

          For more on what we cover, here’s the latest from the Summit; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          explore

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          European regulators recommend Amylyx's ALS drug be rejected
          European regulators recommend Amylyx's ALS drug be rejected

          PauloAmorim/VWPicsviaAPImagesLONDON—EuropeanregulatorsonFridayreiteratedtheirviewthatanALStreatmentf

          read more
          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more

          Life sciences deals on track to hit lowest point since 2017

          AdobeIt’snosecretthatbiotechindustryfundinghasfallenfromitsCovidhighs.Butwithjustafewmonthsleftinthe